Alterations in the histaminergic system in the substantia nigra and striatum of Parkinson's patients: A postmortem study

Neurobiology of Aging

Volumn 33, Issue 7, 2012, Pages 1488.e1-1488.e13

  Shan, Ling ^a,b   Bossers, Koen ^b   Luchetti, Sabina ^b   Balesar, Rawien ^b   Lethbridge, Natasha ^c   Chazot, Paul L ^c   Bao, Ai Min ^a   Swaab, Dick F ^b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^c DURHAM UNIVERSITY   (United Kingdom)

Author keywords

Caudate; Dopaminergic neurons; Histaminergic system; Parkinson's disease; Putamen; Substantia nigra

Indexed keywords

HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; HISTAMINE H3 RECEPTOR; HISTAMINE H4 RECEPTOR; HISTAMINE METHYLTRANSFERASE; MESSENGER RNA;

AGED; ARTICLE; BRAIN NERVE CELL; CADAVER; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE DURATION; FEMALE; GENE EXPRESSION; HISTAMINERGIC SYSTEM; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALE; NERVOUS SYSTEM; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PUTAMEN; QUANTITATIVE ANALYSIS; SUBSTANTIA NIGRA;

EID: 84861184424     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2011.10.016     Document Type: Article

References (61)

1. Agundez J.A., Luengo A., Herraez O., Martinez C., Alonso-Navarro H., Jimenez-Jimenez F.J., Garcia-Martin E. Nonsynonymous polymorphisms of histamine-metabolising enzymes in patients with Parkinson's disease. Neuromol. Med 2008, 10:10-16.
2. Anichtchik O.V., Huotari M., Peitsaro N., Haycock J.W., Mannisto P.T., Panula P. Modulation of histamine H3 receptors in the brain of 6-hydroxydopamine-lesioned rats. Eur. J. Neurosci 2000, 12:3823-3832.
3. Anichtchik O.V., Peitsaro N., Rinne J.O., Kalimo H., Panula P. Distribution and modulation of histamine H(3) receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease. Neurobiol. Dis 2001, 8:707-716.
4. Anichtchik O.V., Rinne J.O., Kalimo H., Panula P. An altered histaminergic innervation of the substantia nigra in Parkinson's disease. Exp. Neurol 2000, 163:20-30.
5. Arrang J.M., Morisset S., Gbahou F. Constitutive activity of the histamine H3 receptor. Trends Pharmacol. Sci 2007, 28:350-357.
6. Bakker R.A., Lozada A.F., van Marle A., Shenton F.C., Drutel G., Karlstedt K., Hoffmann M., Lintunen M., Yamamoto Y., van Rijn R.M., Chazot P.L., Panula P., Leurs R. Discovery of naturally occurring splice variants of the rat histamine H3 receptor that act as dominant-negative isoforms. Mol. Pharmacol 2006, 69:1194-1206.
7. Barnes W.G., Hough L.B. Membrane-bound histamine N-methyltransferase in mouse brain: possible role in the synaptic inactivation of neuronal histamine. J. Neurochem 2002, 82:1262-1271.
8. Bossers K., Meerhoff G., Balesar R., van Dongen J.W., Kruse C.G., Swaab D.F., Verhaagen J. Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death. Brain Pathol 2009, 19:91-107.
9. Braak H., Del Tredici K. Neuroanatomy and pathology of sporadic Parkinson's disease. Adv. Anat. Embryol. Cell Biol 2009, 201:1-119.
10. Cannon K.E., Chazot P.L., Hann V., Shenton F., Hough L.B., Rice F.L. Immunohistochemical localization of histamine H3 receptors in rodent skin, dorsal root ganglia, superior cervical ganglia, and spinal cord: potential antinociceptive targets. Pain 2007, 129:76-92.
11. Chazot P.L., Hann V., Wilson C., Lees G., Thompson C.L. Immunological identification of the mammalian H3 histamine receptor in the mouse brain. Neuroreport 2001, 12:259-262.
12. Chen K., Wang J.J., Yung W.H., Chan Y.S., Chow B.K. Excitatory effect of histamine on neuronal activity of rat globus pallidus by activation of H2 receptors in vitro. Neurosci. Res 2005, 53:288-297.
13. Cogé F., Guénin S.P., Audinot V., Renouard-Try A., Beauverger P., Macia C., Ouvry C., Nagel N., Rique H., Boutin J.A., Galizzi J.P. Genomic organization and characterization of splice variants of the human histamine H3 receptor. Biochem. J 2001, 355:279-288.
14. Connelly W.M., Shenton F.C., Lethbridge N., Leurs R., Waldvogel H.J., Faull R.L., Lees G., Chazot P.L. The histamine H4 receptor is functionally expressed on neurons in the mammalian CNS. Br. J. Pharmacol 2009, 157:55-63.
15. Drutel G., Peitsaro N., Karlstedt K., Wieland K., Smit M.J., Timmerman H., Panula P., Leurs R. Identification of rat H3 receptor isoforms with different brain expression and signaling properties. Mol. Pharmacol 2001, 59:1-8.
16. Duch D.S., Bowers S.W., Nichol C.A. Elevation of brain histamine levels by diaminopyrimidine inhibitors of histamine N-methyl transferase. Biochem. Pharmacol 1978, 27:1507-1509.
17. Ericson H., Watanabe T., Kohler C. Morphological analysis of the tuberomammillary nucleus in the rat brain: delineation of subgroups with antibody against L-histidine decarboxylase as a marker. J. Comparative Neurol 1987, 263:1-24.
18. Fleige S., Pfaffl M.W. RNA integrity and the effect on the real-time qRT-PCR performance. Mol. Aspects Med 2006, 27:126-139.
19. Fogel W.A., Michelsen K.A., Granerus G., Sasiak K., Andrzejewski W., Panula P., Maslinski C. Neuronal storage of histamine in the brain and tele-methylimidazoleacetic acid excretion in portocaval shunted rats. J. Neurochem 2002, 80:375-382.
20. Garcia M., Floran B., Arias-Montaño J.A., Young J.M., Aceves J. Histamine H3 receptor activation selectively inhibits dopamine D1 receptor-dependent [3H]GABA release from depolarization-stimulated slices of rat substantia nigra pars reticulata. Neuroscience 1997, 80:241-249.
21. Giannoni P., Passani M.B., Nosi D., Chazot P.L., Shenton F.C., Medhurst A.D., Munari L., Blandina P. Heterogeneity of histaminergic neurons in the tuberomammillary nucleus of the rat. Eur. J. Neurosci 2009, 29:2363-2374.
22. Goldschmidt R.C., Hough L.B., Glick S.D. Rat brain mast cells: contribution to brain histamine levels. J. Neurochem 1985, 44:1943-1947.
23. Goodchild R.E., Court J.A., Hobson I., Piggott M.A., Perry R.H., Ince P., Jaros E., Perry E.K. Distribution of histamine H3-receptor binding in the normal human basal ganglia: comparison with Huntington's and Parkinson's disease cases. Eur. J. Neurosci 1999, 11:449-456.
24. Haas H., Panula P. The role of histamine and the tuberomamillary nucleus in the nervous system. Nat. Rev. Neurosci 2003, 4:121-130.
25. Haas H.L., Sergeeva O.A., Selbach O. Histamine in the nervous system. Physiol. Rev 2008, 88:1183-1241.
26. Huszti Z., Magyar K., Kálmán M. Contribution of glial cells to histamine inactivation. Agents Actions 1990, 30:237-239.
27. Jurič D.M., Mele T., Carman-Kržan M. Involvement of histaminergic receptor mechanisms in the stimulation of NT-3 synthesis in astrocytes. Neuropharmacology 2011, 60:1309-1317.
28. Kamphuis W., Schneemann A., van Beek L.M., Smit A.B., Hoyng P.F., Koya E. Prostanoid receptor gene expression profile in human trabecular meshwork: a quantitative real-time PCR approach. Invest. Ophthalmol. Vis. Sci 2001, 42:3209-3215.
29. Keeling B.H., Vilarino-Guell C., Soto-Ortolaza A.I., Ross O.A., Uitti R.J., Rajput A., Wszolek Z.K., Farrer M.J. Histamine N-methyltransferase Thr105Ile is not associated with Parkinson's disease or essential tremor. Parkinsonism Relat. Disord 2011, 16:112-114.
30. Ledesma M.C., Garcia-Martin E., Alonso-Navarro H., Martinez C., Jimenez-Jimenez F.J., Benito-Leon J., Puertas I., Rubio L., Lopez-Alburquerque T., Agundez J.A. The nonsynonymous Thr105Ile polymorphism of the histamine N-methyltransferase is associated to the risk of developing essential tremor. Neuromol. Med 2008, 10:356-361.
31. Lee S.B., Chang B.J., Lee H.S. Organization of histamine-immunoreactive, tuberomammillary neurons projecting to the dorsal tier of the substantia nigra compacta in the rat. Brain Res 2008, 1203:79-88.
32. Liu C.Q., Chen Z., Liu F.X., Hu D.N., Luo J.H. Involvement of brain endogenous histamine in the degeneration of dopaminergic neurons in 6-hydroxydopamine-lesioned rats. Neuropharmacology 2007, 53:832-841.
33. Liu C.Q., Hu D.N., Liu F.X., Chen Z., Luo J.H. Apomorphine-induced turning behavior in 6-hydroxydopamine lesioned rats is increased by histidine and decreased by histidine decarboxylase, histamine H1 and H2 receptor antagonists, and an H3 receptor agonist. Pharmacol. Biochem. Behav 2008, 90:325-330.
34. Luchetti S., Bossers K., Frajese G.V., Swaab D.F. Neurosteroid biosynthetic pathway changes in substantia nigra and caudate nucleus in Parkinson's disease. Brain Pathol 2010, 20:945-951.
35. Maisonnette S., Huston J.P., Brandao M., Schwarting R.K. Behavioral asymmetries and neurochemical changes after unilateral lesions of tuberomammillary nucleus or substantia nigra. Exp. Brain Res 1998, 120:273-282.
36. Martinez-Mir M.I., Pollard H., Moreau J., Arrang J.M., Ruat M., Traiffort E., Schwartz J.C., Palacios J.M. Three histamine receptors (H1, H2 and H3) visualized in the brain of human and non-human primates. Brain Res 1990, 526:322-327.
37. McGeer P.L., McGeer E.G. Glial reactions in Parkinson's disease. Mov. Disord 2008, 23:474-483.
38. Mezzomo K., Cumming P., Minuzzi L. Comparison of the binding distribution of agonist and antagonist ligands for histamine H3 receptors in pig brain by quantitative autoradiography. Eur. J. Pharmacol 2007, 564:75-79.
39. Morisset S., Sasse A., Gbahou F., Héron A., Ligneau X., Tardivel-Lacombe J., Schwartz J.C., Arrang J.M. The rat H3 receptor: gene organization and multiple isoforms. Biochem. Biophys. Res. Commun 2001, 280:75-80.
40. Nishibori M., Tahara A., Sawada K., Sakiyama J., Nakaya N., Saeki K. Neuronal and vascular localization of histamine N-methyltransferase in the bovine central nervous system. Eur. J. Neurosci 2000, 12:415-424.
41. Panula P., Airaksinen M.S., Pirvola U., Kotilainen E. A histamine-containing neuronal system in human brain. Neuroscience 1990, 34:127-132.
42. Panula P., Pirvola U., Auvinen S., Airaksinen M.S. Histamine-immunoreactive nerve fibers in the rat brain. Neuroscience 1989, 28:585-610.
43. Panula P., Yang H.Y.T., Costa E. Histamine-containing neurons in the rat hypothalamus. Proc. Natl. Acad. Sci 1984, 81:2572-2576.
44. Palada V., Terzic J., Mazzulli J., Bwala G., Hagenah J., Peterlin B., Hung A.Y., Klein C., Krainc D. Histamine N-methyltransferase Thr105Ile polymorphism is associated with Parkinson's disease. Neurobiol. Aging 2011, 10.1016/J.neurobioloaging.2011.06.015.
45. Pillot C., Heron A., Cochois V., Tardivel-Lacombe J., Ligneau X., Schwartz J.C., Arrang J.M. A detailed mapping of the histamine H(3) receptor and its gene transcripts in rat brain. Neuroscience 2002, 114:173-193.
46. Poli E., Todorov S., Pozzoli C., Bertaccini G. Presynaptic histamine H2 receptors modulate the sympathetic nerve transmission in the isolated rat vas deferens; no role for H3-receptors. Agents Act 1994, 42:95-100.
47. Pollard H., Moreau J., Arrang J.M., Schwartz J.C. A detailed autoradiographic mapping of histamine H3 receptors in rat brain areas. Neuroscience 1993, 52:169-189.
48. Rafałowska U., Waşkiewicz J., Albrecht J. Is neurotransmitter histamine predominantly inactivated in astrocytes?. Neurosci. Lett 1987, 80:106-110.
49. Rinne J.O., Anichtchik O.V., Eriksson K.S., Kaslin J., Tuomisto L., Kalimo H., Röyttä M., Panula P. Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy. J. Neurochem 2002, 81:954-960.
50. Ruat M., Traiffort E., Bouthenet M.L., Schwartz J.C., Hirschfeld J., Buschauer A., Schunack W. Reversible and irreversible labeling and autoradiographic localization of the cerebral histamine H2 receptor using [125I]iodinated probes. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:1658-1662.
51. Ryu J.H., Yanai K., Watanabe T. Marked increase in histamine H3 receptors in the striatum and substantia nigra after 6-hydroxydopamine-induced denervation of dopaminergic neurons: an autoradiographic study. Neurosci. Lett 1994, 178:19-22.
52. Shan L., Liu C.Q., Balesar R., Hofman M.A., Bao A.M., Swaab D.F. Neuronal histamine production remains unaltered in Parkinson's disease despite the accumulation of Lewy bodies and Lewy neurites in the tuberomamillary nucleus. Neurobiol. Aging 2011, 10.1016/j.neurobioloaging.2011.01.004.
53. Threlfell S., Cragg S.J., Kalló I., Turi G.F., Coen C.W., Greenfield S.A. Histamine H3 receptors inhibit serotonin release in substantia nigra pars reticulata. J. Neurosci 2004, 24:8704-8710.
54. Timm J., Marr L., Werthwein S., Elz S., Schunack W., Schlicker E. H2 receptor-mediated facilitation and H3 receptor-mediated inhibition of noradrenaline release in the guinea-pig brain. Naunyn Schmiedebergs Arch Pharmacol 1998, 357:232-239.
55. van der Sluis P.J., Pool C.W., Sluiter A.A. Immunochemical detection of peptides and proteins on press-blots after direct tissue gel isoelectric focusing. Electrophoresis 1988, 9:654-661.
56. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002, 3. RESEARCH0034.
57. Vizuete M.L., Merino M., Venero J.L., Santiago M., Cano J., Machado A. Histamine infusion induces a selective dopaminergic neuronal death along with an inflammatory reaction in rat substantia nigra. J. Neurochem 2000, 75:540-552.
58. Vizuete M.L., Traiffort E., Bouthenet M.L., Ruat M., Souil E., Tardivel-Lacombe J., Schwartz J.C. Detailed mapping of the histamine H2 receptor and its gene transcripts in guinea-pig brain. Neuroscience 1997, 80:321-343.
59. Watanabe T., Taguchi Y., Shiosaka S., Tanaka J., Kubota H., Terano Y., Tohyama M., Wada H. Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res 1984, 295:13-25.
60. Yamakami J., Sakurai E., Kuramasu A., Sakurai E., Yanai K., Watanabe T., Tanaka Y. L-Histidine decarboxylase protein and activity in rat brain microvascular endothelial cells. Inflamm. Res 2000, 49:231-235.
61. Yanovsky Y., Li S., Klyuch B.P., Yao Q., Blandina P., Passani M.B., Lin J.S., Haas H., Sergeeva O.A. L-Dopa activates histaminergic neurons. J. Physiol 2011, 589:1349-1366.